9th Annual MSK Symposium on Lymphoma — On Demand 2025

$129.99

Videos+PDF

Category: , ,
Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Description

Overview

9th Annual MSK Symposium on Lymphoma — On Demand 2025 offers a comprehensive review of the latest advancements in lymphoma, originally recorded live in April 2025. This symposium features national and international experts presenting updated lymphoma biology, diagnostic techniques, and innovative treatment strategies. It emphasizes clinical management of common lymphoma subtypes, new drug developments, and translational research to enhance patient care.

On-demand oncology & hematology education — accessible anytime, anywhere.

Agenda

This on-demand symposium covers a broad range of clinically relevant lymphoma topics, supported by expert keynote presentations.

  • Current Challenges in the Management of Follicular Lymphoma
  • Advances in Therapeutic Strategies for Mantle Cell Lymphoma
  • Hodgkin Lymphoma
  • The Dark Side of B-Cells
  • Improving Outcomes for Patients with T-Cell Lymphoma
  • Aggressive B-Cell Lymphoma: Addressing Remaining Gaps on the Path to a Definitive Cure
  • CAR T-Cell Therapies in Large B-Cell Lymphoma: Who, When, and How?
  • Chris Flowers, MD, MPH — MD Anderson Cancer Center: Epidemiology and Outcomes in Lymphoma
  • Margaret Shipp, MD — Dana-Farber Cancer Institute: Biology of Hodgkin Lymphoma
  • David Maloney, MD, PhD — Fred Hutchinson Cancer Research Center: Lessons and Challenges

Objectives

At the conclusion of this symposium, attendees will be able to:

  • Describe recent advances in lymphoma classification
  • Discuss first line treatment options in most frequent lymphoma entities
  • Describe new agents’ mode of actions, efficacy, and side effects
  • Discuss options and recommendations for patients in the relapse refractory setting
  • Provide adequate information to help shared decision-making with patients regarding their treatment

Speakers

  • Chris Flowers, MD, MPH — MD Anderson Cancer Center
  • Margaret Shipp, MD — Dana-Farber Cancer Institute
  • David Maloney, MD, PhD — Fred Hutchinson Cancer Research Center

Target Audience

This program is designed for internists, oncologists, hematologists, medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and research of lymphoma.

Why This Topic Matters

The 9th Annual MSK Symposium on Lymphoma — On Demand 2025 addresses critical advances in lymphoma relevant to oncology and hematology professionals. Its focus on evolving diagnostic and therapeutic strategies supports clinicians in strengthening expertise and confidence in managing lymphoma subtypes.

This MedHub Central resource enhances knowledge in lymphoma biology and clinical care, serving as a valuable reference for specialists aiming to remain current with progressive developments in lymphoma management.